Olivia Newton-John Cancer Research Institute   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Heidelberg Australia (2014)

Organization Overview

First Clinical Trial
2016
NCT02824965
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Olivia Newton-John Cancer Research Institute | Olivia Newton-John Cancer Wellness and Research Centre